Veterinary Cancer Society
Balance Sheet
Fiscal Year Start:
Jan 1
Data visualization unavailable
Assets in 2024 (Year End)
$3,284,300
Investments
92%
Cash & Equivalents
7%
Property, Plant, & Equipment (net)
<1%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Other Assets
0%
Liabilities in 2024 (Year End)
-$1,083
Other Liabilities
N/A
Grants Payable
N/A
Deferred Revenue
N/A
Tax-Exempt Bond Liabilities
N/A
Custodial & Escrow Liabilities
N/A
Notes Payable / Debt (Non-Related)
N/A
Related-Party Payables
N/A
Assets
2023
2024
Change
Cash & Equivalents
$231,298
$243,697
+5%
Receivables (Non-Related)
-$5,716
$4,450
-178%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$2,639,306
$3,030,792
+15%
Property, Plant, & Equipment (net)
$5,670
$5,361
-5%
Other Assets
-
-
-
Total Assets
$2,870,558
$3,284,300
+14%
Liabilities
2023
2024
Change
Payables & Accruals
-$1,000
-$1,518
+52%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-$10,234
$435
-104%
Total Liabilities
-$11,234
-$1,083
-90%
Net assets
2023
2024
Change
Restricted Net Assets
N/A
N/A
N/A
Unrestricted Net Assets
N/A
N/A
N/A
Net assets
2023
2024
Change
Net assets
+$2,881,792
+$3,285,383
+14%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)